Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4
Authors
Keywords
-
Journal
OncoImmunology
Volume 6, Issue 9, Pages e1342023
Publisher
Informa UK Limited
Online
2017-07-06
DOI
10.1080/2162402x.2017.1342023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Side-effects of checkpoint inhibitor-based combination therapy
- (2016) Hampig R. Kourie et al. CURRENT OPINION IN ONCOLOGY
- Immunotherapy in kidney cancer
- (2016) Hans Hammers CURRENT OPINION IN UROLOGY
- Ipilimumab plus nivolumab for advanced melanoma
- (2016) Jessica C Hassel LANCET ONCOLOGY
- Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling
- (2016) Yanwen Zhang et al. TUMOR BIOLOGY
- Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases
- (2016) Fabio Morandi et al. Journal of Immunology Research
- A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G
- (2015) Snezana Djurisic et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors
- (2015) Xunlei Kang et al. CELL CYCLE
- A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
- (2015) Edgardo D. Carosella et al. EUROPEAN UROLOGY
- ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer
- (2015) Pei Zhang et al. FEBS LETTERS
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer
- (2015) Pei Zhang et al. Oncotarget
- Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial
- (2014) T. K. Choueiri et al. CLINICAL CANCER RESEARCH
- Inhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10
- (2014) Jie Liu et al. Diagnostic Pathology
- In vivoevidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance
- (2014) Laure Loumagne et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumour immunity gets a boost
- (2014) Jedd D. Wolchok et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17
- (2011) S. Agaugue et al. BLOOD
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) B. Escudier et al. ANNALS OF ONCOLOGY
- Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade
- (2010) Jeffrey Weber SEMINARS IN ONCOLOGY
- Expression of Ig-Like Transcript 4 Inhibitory Receptor in Human Non-small Cell Lung Cancer
- (2008) Yuping Sun et al. CHEST
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started